File S10232 ("Speed up cancer treatment approvals for patients") is before the New York Legislature and has not been decided. Latest step (May 7, 2026): In Senate Committee.
New York file S10232, before the New York Legislature. Still to be decided as of 2026-05-07.
Cancer patients skip insurer approval waits for guideline-backed drugs Patients whose doctors recommend cancer treatments aligned with National Comprehensive Cancer Network Guidelines receive those treatments immediately rather than waiting days or weeks for insurance company approval.
Oncologists gain autonomy; insurers lose cost-control leverage on cancer care The bill reduces insurers' ability to second-guess oncologists' treatment decisions, shifting clinical authority toward doctors but potentially increasing insurer costs if guideline-based treatments are more expensive than alternatives.
Relates to not requiring a prior authorization determination for certain categories of cancer treatments based on National Comprehensive Cancer Network Guidelines.
Read the official record for S10232
See everything up for a vote · This week in New York · See what we have filed with the clerk